Yahoo
Tokyo - Delayed Quote JPY

Asahi Kasei Corporation (3407.T)

1,579.50 -25.00 (-1.56%)
At close: 3:30:00 PM GMT+9
Chart Range Bar
Loading chart for 3407.T
  • Previous Close 1,604.50
  • Open 1,604.50
  • Bid 1,578.00 x --
  • Ask 1,582.00 x --
  • Day's Range 1,574.50 - 1,605.00
  • 52 Week Range 1,157.00 - 1,906.00
  • Volume 4,151,800
  • Avg. Volume 4,882,785
  • Market Cap (intraday) 2.106T
  • Beta (5Y Monthly) 0.63
  • PE Ratio (TTM) 11.11
  • EPS (TTM) 142.12
  • Earnings Date Nov 5, 2026
  • Forward Dividend & Yield 44.00 (2.74%)
  • Ex-Dividend Date Mar 30, 2027
  • 1y Target Est 1,981.67

Asahi Kasei Corporation engages in material, homes, and healthcare businesses in Japan, the United States, China, and internationally. The company offers Pimel, a photosensitive PI material applied for semiconductor applications, such as buffer coating, passivation layers, and dielectric layers; Sunfort, a dry film photoresist; Novacure, a latent curing agent for epoxy resin; glass fabric for printed circuit boards; plastic optical fiber; sensors and devices; artificial suede products under the Dinamica name; Microza UF and MF industrial membranes and systems; Aciplex membranes, process equipment, and systems for caustic soda production; alkaline water electrolyzer for producing hydrogen from renewable energy Aqualyzer; Hipore, a microporous polyolefin sheet which prevents the anode and cathode; Celgard, a lithium-ion battery separator; photopolymers and platemaking systems; and fiber products under the Bemberg, Bemliese, NanoAct, and ROICA names. It also provides cling film, bags, and containers under the Saran Wrap, Ziploc, and Cookper names; packaging products under the Suntec, Barrialon, PVDC latex, and Saran fiber names; pharmaceutical and food additives under the Ceolous and Celphere names; and clads and anchors under the Baclad and AR Chemical Setter names. In addition, the company offers prescription drugs in the fields of orthopedics, critical/intensive care, urology, immune system, and central nervous system; virus removal filters; wearable defibrillators, temperature management systems, pre-hospital, and hospital data management systems; overseas homes, unit homes and apartment buildings, and real estate-related operations; autoclaved aerated concretes, foundation systems, thermal insulations, and structural systems and component products; polymers, monomers, foamed products, and cleaners; and synthetic rubber, elastomers, and intermediates and inorganic chemicals. Asahi Kasei Corporation was founded in 1922 and is headquartered in Chiyoda, Japan.

www.asahi-kasei.com

47,895

Full Time Employees

March 31

Fiscal Year Ends

Industrials

Sector

Conglomerates

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

3407.T
16.90%
Nikkei 225 (^N225)
25.31%

1-Year Return

3407.T
37.31%
Nikkei 225 (^N225)
20.36%

3-Year Return

3407.T
85.62%
Nikkei 225 (^N225)
97.44%

5-Year Return

3407.T
56.30%
Nikkei 225 (^N225)
113.69%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY27
Revenue 826.16B
Earnings 53.77B
Profit Margin 6.51%

Q2

FY26

Q3

FY26

Q4

FY26

Q1

FY27

0
200B
400B
600B
800B
5.0%
5.5%
6.0%
6.5%
7.0%

Analyst Insights

View More

Analyst Price Targets

1,400.00 Low
1,981.67 Average
1,579.50 Current
2,500.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.10%

  • Return on Assets (ttm)

    3.84%

  • Return on Equity (ttm)

    9.75%

  • Revenue (ttm)

    3.16T

  • Net Income Avi to Common (ttm)

    192.84B

  • Diluted EPS (ttm)

    142.12

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    387.36B

  • Total Debt/Equity (mrq)

    56.86%

  • Levered Free Cash Flow (ttm)

    -24.39B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: